Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 911

1.

DETECTION OF CIRCULATING TUMOR DNA IN PATIENTS WITH PANCREATIC CANCER USING DIGITAL NEXT-GENERATION SEQUENCING.

Macgregor-Das A, Yu J, Tamura K, Abe T, Suenaga M, Shindo K, Borges M, Koi C, Kohi S, Sadakari Y, Molin MD, Almario JA, Ford M, Chuidian M, Burkhart R, He J, Hruban RH, Eshleman JR, Klein AP, Wolfgang CL, Canto MI, Goggins M.

J Mol Diagn. 2020 Mar 20. pii: S1525-1578(20)30056-8. doi: 10.1016/j.jmoldx.2020.02.010. [Epub ahead of print]

PMID:
32205290
2.

The Evolutionary Origins of Recurrent Pancreatic Cancer.

Sakamoto H, Attiyeh MA, Gerold JM, Makohon-Moore AP, Hayashi A, Hong J, Kappagantula R, Zhang L, Melchor JP, Reiter JG, Heyde A, Bielski CM, Penson AV, Gonen M, Chakravarty D, O'Reilly EM, Wood LD, Hruban RH, Nowak MA, Socci ND, Taylor BS, Iacobuzio-Donahue CA.

Cancer Discov. 2020 Mar 19. pii: CD-19-1508. doi: 10.1158/2159-8290.CD-19-1508. [Epub ahead of print]

3.

Invasive Intraductal Papillary Mucinous Neoplasms: CT Features of Colloid Carcinoma Versus Tubular Adenocarcinoma of the Pancreas.

Fouladi DF, Raman SP, Hruban RH, Fishman EK, Kawamoto S.

AJR Am J Roentgenol. 2020 Mar 4:1-9. doi: 10.2214/AJR.19.21824. [Epub ahead of print]

PMID:
32130045
4.

Pancreatic acinar cell carcinomas and mixed acinar-neuroendocrine carcinomas are more clinically aggressive than grade 1 pancreatic neuroendocrine tumours.

Kim JY, Brosnan-Cashman JA, Kim J, An S, Lee KB, Kim H, Park DY, Jang KT, Oh YH, Hruban RH, Heaphy CM, Hong SM.

Pathology. 2020 Apr;52(3):336-347. doi: 10.1016/j.pathol.2020.01.437. Epub 2020 Feb 25.

PMID:
32111396
5.

Assessing aneuploidy with repetitive element sequencing.

Douville C, Cohen JD, Ptak J, Popoli M, Schaefer J, Silliman N, Dobbyn L, Schoen RE, Tie J, Gibbs P, Goggins M, Wolfgang CL, Wang TL, Shih IM, Karchin R, Lennon AM, Hruban RH, Tomasetti C, Bettegowda C, Kinzler KW, Papadopoulos N, Vogelstein B.

Proc Natl Acad Sci U S A. 2020 Mar 3;117(9):4858-4863. doi: 10.1073/pnas.1910041117. Epub 2020 Feb 19.

PMID:
32075918
6.

Cell fitness screens reveal a conflict between LINE-1 retrotransposition and DNA replication.

Ardeljan D, Steranka JP, Liu C, Li Z, Taylor MS, Payer LM, Gorbounov M, Sarnecki JS, Deshpande V, Hruban RH, Boeke JD, Fenyö D, Wu PH, Smogorzewska A, Holland AJ, Burns KH.

Nat Struct Mol Biol. 2020 Feb;27(2):168-178. doi: 10.1038/s41594-020-0372-1. Epub 2020 Feb 10.

PMID:
32042151
7.

Generation and characterization of a cell line from an intraductal tubulopapillary neoplasm of the pancreas.

Felsenstein M, Trujillo MA, Huang B, Nanda N, Jiang Z, Jeong YJ, Pflüger M, Goggins MG, Hruban RH, Thompson ED, Heaphy CM, Roberts NJ, Wood LD.

Lab Invest. 2020 Jan 31. doi: 10.1038/s41374-020-0372-0. [Epub ahead of print]

PMID:
32005909
8.

Recent trends in the incidence and survival of Stage 1A Pancreatic Cancer: A Surveillance, Epidemiology, and End Results analysis.

Blackford AL, Canto MI, Klein AP, Hruban RH, Goggins M.

J Natl Cancer Inst. 2020 Jan 20. pii: djaa004. doi: 10.1093/jnci/djaa004. [Epub ahead of print]

PMID:
31958122
9.

Multiple Carcinomas and Intraepithelial Neoplasms in a Case of Familial Pancreatic Cancer: Rapid Morphological Changes in the Pancreatic Cyst and Pathological Lesions Undetected by Clinical Images.

Matsubayashi H, Notohara K, Hruban RH, Satoh T, Kaneko J, Sato J, Ishiwatari H, Ashida R, Uesaka K, Kiyozumi Y, Ono H.

Intern Med. 2020 Jan 9. doi: 10.2169/internalmedicine.3882-19. [Epub ahead of print]

10.

Pitfalls in the MDCT of pancreatic cancer: strategies for minimizing errors.

Haj-Mirzaian A, Kawamoto S, Zaheer A, Hruban RH, Fishman EK, Chu LC.

Abdom Radiol (NY). 2020 Feb;45(2):457-478. doi: 10.1007/s00261-019-02390-9. Review.

PMID:
31897686
11.

Revisiting the tumorigenesis timeline with a data-driven generative model.

Lahouel K, Younes L, Danilova L, Giardiello FM, Hruban RH, Groopman J, Kinzler KW, Vogelstein B, Geman D, Tomasetti C.

Proc Natl Acad Sci U S A. 2020 Jan 14;117(2):857-864. doi: 10.1073/pnas.1914589117. Epub 2019 Dec 27.

12.

Three-dimensional visualization of cleared human pancreas cancer reveals that sustained epithelial-to-mesenchymal transition is not required for venous invasion.

Hong SM, Jung D, Kiemen A, Gaida MM, Yoshizawa T, Braxton AM, Noë M, Lionheart G, Oshima K, Thompson ED, Burkhart R, Wu PH, Wirtz D, Hruban RH, Wood LD.

Mod Pathol. 2019 Nov 7. doi: 10.1038/s41379-019-0409-3. [Epub ahead of print]

PMID:
31700162
13.

Recurrent Rearrangements in PRKACA and PRKACB in Intraductal Oncocytic Papillary Neoplasms of the Pancreas and Bile Duct.

Singhi AD, Wood LD, Parks E, Torbenson MS, Felsenstein M, Hruban RH, Nikiforova MN, Wald AI, Kaya C, Nikiforov YE, Favazza L, He J, McGrath K, Fasanella KE, Brand RE, Lennon AM, Furlan A, Dasyam AK, Zureikat AH, Zeh HJ, Lee K, Bartlett DL, Slivka A.

Gastroenterology. 2020 Feb;158(3):573-582.e2. doi: 10.1053/j.gastro.2019.10.028. Epub 2019 Oct 31.

14.

Gene Variants That Affect Levels of Circulating Tumor Markers Increase Identification of Patients With Pancreatic Cancer.

Abe T, Koi C, Kohi S, Song KB, Tamura K, Macgregor-Das A, Kitaoka N, Chuidian M, Ford M, Dbouk M, Borges M, He J, Burkhart R, Wolfgang CL, Klein AP, Eshleman JR, Hruban RH, Canto MI, Goggins M.

Clin Gastroenterol Hepatol. 2019 Oct 30. pii: S1542-3565(19)31238-8. doi: 10.1016/j.cgh.2019.10.036. [Epub ahead of print]

15.

Management of patients with increased risk for familial pancreatic cancer: updated recommendations from the International Cancer of the Pancreas Screening (CAPS) Consortium.

Goggins M, Overbeek KA, Brand R, Syngal S, Del Chiaro M, Bartsch DK, Bassi C, Carrato A, Farrell J, Fishman EK, Fockens P, Gress TM, van Hooft JE, Hruban RH, Kastrinos F, Klein A, Lennon AM, Lucas A, Park W, Rustgi A, Simeone D, Stoffel E, Vasen HFA, Cahen DL, Canto MI, Bruno M; International Cancer of the Pancreas Screening (CAPS) consortium.

Gut. 2020 Jan;69(1):7-17. doi: 10.1136/gutjnl-2019-319352. Epub 2019 Oct 31.

PMID:
31672839
16.

Biphenotypic Differentiation of Pancreatic Cancer in 3-Dimensional Culture.

Matsushita Y, Smith B, Delannoy M, Trujillo MA, Chianchiano P, McMillan R, Kamiyama H, Liang H, Thompson ED, Hruban RH, Matsui W, Wood LD, Roberts NJ, Eshleman JR.

Pancreas. 2019 Oct;48(9):1225-1231. doi: 10.1097/MPA.0000000000001390.

PMID:
31593010
17.

Surveillance for pancreatic cancer in high-risk individuals.

Konings ICAW, Canto MI, Almario JA, Harinck F, Saxena P, Lucas AL, Kastrinos F, Whitcomb DC, Brand RE, Lachter J, Malleo G, Paiella S, Syngal S, Saltzman JR, Stoffel EM, van Hooft JE, Hruban RH, Poley JW, Fockens P, Goggins MG, Bruno MJ; International CAncer of the Pancreas Screening (CAPS) Consortium.

BJS Open. 2019 Jul 2;3(5):656-665. doi: 10.1002/bjs5.50180. eCollection 2019 Oct.

18.

Cell division rates decrease with age, providing a potential explanation for the age-dependent deceleration in cancer incidence.

Tomasetti C, Poling J, Roberts NJ, London NR Jr, Pittman ME, Haffner MC, Rizzo A, Baras A, Karim B, Kim A, Heaphy CM, Meeker AK, Hruban RH, Iacobuzio-Donahue CA, Vogelstein B.

Proc Natl Acad Sci U S A. 2019 Oct 8;116(41):20482-20488. doi: 10.1073/pnas.1905722116. Epub 2019 Sep 23.

19.

The "Race" Toward Diversity, Inclusion, and Equity in Pathology: The Johns Hopkins Experience.

Ware AD, Murdock T, Voltaggio L, Windon AL, Troncoso JC, Hruban RH, White MJ.

Acad Pathol. 2019 Sep 8;6:2374289519873104. doi: 10.1177/2374289519873104. eCollection 2019 Jan-Dec.

20.

A semicentennial of pancreatic pathology: the genetic revolution is here, but don't throw the baby out with the bath water!

Hruban RH, Klimstra DS, Zamboni G, Klöppel G.

Hum Pathol. 2020 Jan;95:99-112. doi: 10.1016/j.humpath.2019.08.024. Epub 2019 Sep 12.

PMID:
31521627
21.

Application of Deep Learning to Pancreatic Cancer Detection: Lessons Learned From Our Initial Experience.

Chu LC, Park S, Kawamoto S, Wang Y, Zhou Y, Shen W, Zhu Z, Xia Y, Xie L, Liu F, Yu Q, Fouladi DF, Shayesteh S, Zinreich E, Graves JS, Horton KM, Yuille AL, Hruban RH, Kinzler KW, Vogelstein B, Fishman EK.

J Am Coll Radiol. 2019 Sep;16(9 Pt B):1338-1342. doi: 10.1016/j.jacr.2019.05.034. No abstract available.

PMID:
31492412
22.

Screening for Pancreatic Cancer-Is There Hope?

Lennon AM, Hruban RH, Klein AP.

JAMA Intern Med. 2019 Aug 6. doi: 10.1001/jamainternmed.2019.3323. [Epub ahead of print] No abstract available.

PMID:
31386154
23.

Screening for Pancreatic Cancer Gets a D, But the Student Is Improving.

Hruban RH, Lillemoe KD.

JAMA Surg. 2019 Aug 6. doi: 10.1001/jamasurg.2019.2832. [Epub ahead of print] No abstract available.

PMID:
31386099
24.

Annotated normal CT data of the abdomen for deep learning: Challenges and strategies for implementation.

Park S, Chu LC, Fishman EK, Yuille AL, Vogelstein B, Kinzler KW, Horton KM, Hruban RH, Zinreich ES, Fadaei Fouladi D, Shayesteh S, Graves J, Kawamoto S.

Diagn Interv Imaging. 2020 Jan;101(1):35-44. doi: 10.1016/j.diii.2019.05.008. Epub 2019 Jul 26.

PMID:
31358460
25.

A multimodality test to guide the management of patients with a pancreatic cyst.

Springer S, Masica DL, Dal Molin M, Douville C, Thoburn CJ, Afsari B, Li L, Cohen JD, Thompson E, Allen PJ, Klimstra DS, Schattner MA, Schmidt CM, Yip-Schneider M, Simpson RE, Fernandez-Del Castillo C, Mino-Kenudson M, Brugge W, Brand RE, Singhi AD, Scarpa A, Lawlor R, Salvia R, Zamboni G, Hong SM, Hwang DW, Jang JY, Kwon W, Swan N, Geoghegan J, Falconi M, Crippa S, Doglioni C, Paulino J, Schulick RD, Edil BH, Park W, Yachida S, Hijioka S, van Hooft J, He J, Weiss MJ, Burkhart R, Makary M, Canto MI, Goggins MG, Ptak J, Dobbyn L, Schaefer J, Sillman N, Popoli M, Klein AP, Tomasetti C, Karchin R, Papadopoulos N, Kinzler KW, Vogelstein B, Wolfgang CL, Hruban RH, Lennon AM.

Sci Transl Med. 2019 Jul 17;11(501). pii: eaav4772. doi: 10.1126/scitranslmed.aav4772.

PMID:
31316009
26.

Follow-up of Incidentally Detected Pancreatic Cystic Neoplasms: Do Baseline MRI and CT Features Predict Cyst Growth?

Pandey P, Pandey A, Luo Y, Aliyari Ghasabeh M, Khoshpouri P, Ameli S, O'Broin-Lennon AM, Canto M, Hruban RH, Goggins MS, Wolfgang C, Kamel IR.

Radiology. 2019 Sep;292(3):647-654. doi: 10.1148/radiol.2019181686. Epub 2019 Jul 16.

PMID:
31310174
27.

Histomorphology of pancreatic cancer in patients with inherited ATM serine/threonine kinase pathogenic variants.

Hutchings D, Jiang Z, Skaro M, Weiss MJ, Wolfgang CL, Makary MA, He J, Cameron JL, Zheng L, Klimstra DS, Brand RE, Singhi AD, Goggins M, Klein AP, Roberts NJ, Hruban RH.

Mod Pathol. 2019 Dec;32(12):1806-1813. doi: 10.1038/s41379-019-0317-6. Epub 2019 Jul 8.

PMID:
31285527
28.

Well-differentiated Pancreatic Neuroendocrine Tumor in a Patient With Familial Atypical Multiple Mole Melanoma Syndrome (FAMMM).

Noë M, Hackeng WM, de Leng WWJ, Vergeer M, Vleggaar FP, Morsink FHM, Wood LD, Hruban RH, Offerhaus GJA, Brosens LAA.

Am J Surg Pathol. 2019 Sep;43(9):1297-1302. doi: 10.1097/PAS.0000000000001314.

PMID:
31261289
29.

The glycan CA19-9 promotes pancreatitis and pancreatic cancer in mice.

Engle DD, Tiriac H, Rivera KD, Pommier A, Whalen S, Oni TE, Alagesan B, Lee EJ, Yao MA, Lucito MS, Spielman B, Da Silva B, Schoepfer C, Wright K, Creighton B, Afinowicz L, Yu KH, Grützmann R, Aust D, Gimotty PA, Pollard KS, Hruban RH, Goggins MG, Pilarsky C, Park Y, Pappin DJ, Hollingsworth MA, Tuveson DA.

Science. 2019 Jun 21;364(6446):1156-1162. doi: 10.1126/science.aaw3145.

30.

Surgical Outcomes After Pancreatic Resection of Screening-Detected Lesions in Individuals at High Risk for Developing Pancreatic Cancer.

Canto MI, Kerdsirichairat T, Yeo CJ, Hruban RH, Shin EJ, Almario JA, Blackford A, Ford M, Klein AP, Javed AA, Lennon AM, Zaheer A, Kamel IR, Fishman EK, Burkhart R, He J, Makary M, Weiss MJ, Schulick RD, Goggins MG, Wolfgang CL.

J Gastrointest Surg. 2019 Jun 13. doi: 10.1007/s11605-019-04230-z. [Epub ahead of print]

PMID:
31197699
31.

Intraductal Papillary Mucinous Neoplasms Arise From Multiple Independent Clones, Each With Distinct Mutations.

Fischer CG, Beleva Guthrie V, Braxton AM, Zheng L, Wang P, Song Q, Griffin JF, Chianchiano PE, Hosoda W, Niknafs N, Springer S, Dal Molin M, Masica D, Scharpf RB, Thompson ED, He J, Wolfgang CL, Hruban RH, Roberts NJ, Lennon AM, Jiao Y, Karchin R, Wood LD.

Gastroenterology. 2019 Oct;157(4):1123-1137.e22. doi: 10.1053/j.gastro.2019.06.001. Epub 2019 Jun 5.

PMID:
31175866
32.

Circulating Tumor DNA as a Clinical Test in Resected Pancreatic Cancer.

Groot VP, Mosier S, Javed AA, Teinor JA, Gemenetzis G, Ding D, Haley LM, Yu J, Burkhart RA, Hasanain A, Debeljak M, Kamiyama H, Narang A, Laheru DA, Zheng L, Lin MT, Gocke CD, Fishman EK, Hruban RH, Goggins MG, Molenaar IQ, Cameron JL, Weiss MJ, Velculescu VE, He J, Wolfgang CL, Eshleman JR.

Clin Cancer Res. 2019 Aug 15;25(16):4973-4984. doi: 10.1158/1078-0432.CCR-19-0197. Epub 2019 May 29.

PMID:
31142500
33.

Is the Early Detection of Pancreatic Cancer Possible? It Is Good News, Bad News.

Hruban RH.

Pancreas. 2019 May/Jun;48(5):591-593. doi: 10.1097/MPA.0000000000001299. No abstract available.

PMID:
31090658
34.

Multiple KRAS mutations in the non-mucinous epithelial lining in the majority of mucinous cystic neoplasms of the pancreas.

An S, Kim MJ, Kim SJ, Sung YN, Kim YW, Song KB, Hwang DW, Kim SC, Hruban RH, Hong SM.

Histopathology. 2019 Oct;75(4):559-567. doi: 10.1111/his.13897. Epub 2019 Jul 26.

PMID:
31077597
35.

Utility of CT Radiomics Features in Differentiation of Pancreatic Ductal Adenocarcinoma From Normal Pancreatic Tissue.

Chu LC, Park S, Kawamoto S, Fouladi DF, Shayesteh S, Zinreich ES, Graves JS, Horton KM, Hruban RH, Yuille AL, Kinzler KW, Vogelstein B, Fishman EK.

AJR Am J Roentgenol. 2019 Aug;213(2):349-357. doi: 10.2214/AJR.18.20901. Epub 2019 Apr 23.

PMID:
31012758
36.

Promoter methylation of ADAMTS1 and BNC1 as potential biomarkers for early detection of pancreatic cancer in blood.

Eissa MAL, Lerner L, Abdelfatah E, Shankar N, Canner JK, Hasan NM, Yaghoobi V, Huang B, Kerner Z, Takaesu F, Wolfgang C, Kwak R, Ruiz M, Tam M, Pisanic TR 2nd, Iacobuzio-Donahue CA, Hruban RH, He J, Wang TH, Wood LD, Sharma A, Ahuja N.

Clin Epigenetics. 2019 Apr 5;11(1):59. doi: 10.1186/s13148-019-0650-0.

37.

Pancreatic Nerve Sheath Tumors: a Single Institutional Series and Systematic Review of the Literature.

Javed AA, Wright MJ, Hasanain A, Chang K, Burkhart RA, Hruban RH, Thompson E, Fishman EK, Cameron JL, He J, Wolfgang CL, Weiss MJ.

J Gastrointest Surg. 2019 Apr 2. doi: 10.1007/s11605-019-04201-4. [Epub ahead of print]

PMID:
30941687
38.

Deleterious Germline Mutations Are a Risk Factor for Neoplastic Progression Among High-Risk Individuals Undergoing Pancreatic Surveillance.

Abe T, Blackford AL, Tamura K, Ford M, McCormick P, Chuidian M, Almario JA, Borges M, Lennon AM, Shin EJ, Klein AP, Hruban RH, Canto MI, Goggins M.

J Clin Oncol. 2019 May 1;37(13):1070-1080. doi: 10.1200/JCO.18.01512. Epub 2019 Mar 18.

PMID:
30883245
39.

Why is pancreatic cancer so deadly? The pathologist's view.

Hruban RH, Gaida MM, Thompson E, Hong SM, Noë M, Brosens LA, Jongepier M, Offerhaus GJA, Wood LD.

J Pathol. 2019 Jun;248(2):131-141. doi: 10.1002/path.5260. Epub 2019 Apr 15.

PMID:
30838636
40.

Added value of apparent diffusion coefficient in distinguishing between serous and mucin-producing pancreatic cystic neoplasms.

Pandey P, Pandey A, Shao N, Varzaneh FN, Ghasabeh MA, Zharghampour M, Khoshpouri P, Fouladi D, Eng J, O'Broin-Lennon AM, Canto M, Hruban RH, Kamel IR.

Eur Radiol. 2019 Sep;29(9):4660-4669. doi: 10.1007/s00330-019-6010-9. Epub 2019 Feb 14.

PMID:
30762111
41.

Prevalence of Germline Mutations Associated With Cancer Risk in Patients With Intraductal Papillary Mucinous Neoplasms.

Skaro M, Nanda N, Gauthier C, Felsenstein M, Jiang Z, Qiu M, Shindo K, Yu J, Hutchings D, Javed AA, Beckman R, He J, Wolfgang CL, Thompson E, Hruban RH, Klein AP, Goggins M, Wood LD, Roberts NJ.

Gastroenterology. 2019 May;156(6):1905-1913. doi: 10.1053/j.gastro.2019.01.254. Epub 2019 Feb 1.

PMID:
30716324
42.

Genomic analysis identifies frequent deletions of Dystrophin in olfactory neuroblastoma.

Gallia GL, Zhang M, Ning Y, Haffner MC, Batista D, Binder ZA, Bishop JA, Hann CL, Hruban RH, Ishii M, Klein AP, Reh DD, Rooper LM, Salmasi V, Tamargo RJ, Wang Q, Williamson T, Zhao T, Zou Y, Meeker AK, Agrawal N, Vogelstein B, Kinzler KW, Papadopoulos N, Bettegowda C.

Nat Commun. 2018 Dec 21;9(1):5410. doi: 10.1038/s41467-018-07578-z.

43.

Pancreatic cancer arising in the remnant pancreas is not always a relapse of the preceding primary.

Luchini C, Pea A, Yu J, He J, Salvia R, Riva G, Weiss MJ, Bassi C, Cameron JL, Hruban RH, Goggins M, Wolfgang CL, Scarpa A, Wood LD, Lawlor RT.

Mod Pathol. 2019 May;32(5):659-665. doi: 10.1038/s41379-018-0183-7. Epub 2018 Nov 22.

44.

The Johns Hopkins Department of Pathology Novel Organizational Model: A 25-Year-Old Ongoing Experiment.

Sanfilippo F, Burns KH, Borowitz MJ, Jackson JB, Hruban RH.

Acad Pathol. 2018 Nov 14;5:2374289518811145. doi: 10.1177/2374289518811145. eCollection 2018 Jan-Dec.

45.

Single-cell sequencing defines genetic heterogeneity in pancreatic cancer precursor lesions.

Kuboki Y, Fischer CG, Beleva Guthrie V, Huang W, Yu J, Chianchiano P, Hosoda W, Zhang H, Zheng L, Shao X, Thompson ED, Waters K, Poling J, He J, Weiss MJ, Wolfgang CL, Goggins MG, Hruban RH, Roberts NJ, Karchin R, Wood LD.

J Pathol. 2019 Mar;247(3):347-356. doi: 10.1002/path.5194. Epub 2019 Jan 16.

46.

Correction: Non-invasive detection of urothelial cancer through the analysis of driver gene mutations and aneuploidy.

Springer SU, Chen CH, Rodriguez Pena MDC, Li L, Douville C, Wang Y, Cohen JD, Taheri D, Silliman N, Schaefer J, Ptak J, Dobbyn L, Papoli M, Kinde I, Afsari B, Tregnago AC, Bezerra SM, VandenBussche C, Fujita K, Ertoy D, Cunha IW, Yu L, Bivalacqua TJ, Grollman AP, Diaz LA, Karchin R, Danilova L, Huang CY, Shun CT, Turesky RJ, Yun BH, Rosenquist TA, Pu YS, Hruban RH, Tomasetti C, Papadopoulos N, Kinzler KW, Vogelstein B, Dickman KG, Netto GJ.

Elife. 2018 Nov 12;7. pii: e43237. doi: 10.7554/eLife.43237.

47.

Genetic Analysis of Small Well-differentiated Pancreatic Neuroendocrine Tumors Identifies Subgroups With Differing Risks of Liver Metastases.

Pea A, Yu J, Marchionni L, Noe M, Luchini C, Pulvirenti A, de Wilde RF, Brosens LA, Rezaee N, Javed A, Chianchiano P, Gobbo S, Regi P, Salvia R, Bassi C, He J, Weiss MJ, Cameron JL, Offerhaus GJA, Hruban RH, Lawlor RT, Scarpa A, Heaphy CM, Wood LD, Wolfgang CL.

Ann Surg. 2020 Mar;271(3):566-573. doi: 10.1097/SLA.0000000000003022.

PMID:
30339629
48.

A "Clearer" View of Pancreatic Pathology: A Review of Tissue Clearing and Advanced Microscopy Techniques.

Hong SM, Noë M, Hruban CA, Thompson ED, Wood LD, Hruban RH.

Adv Anat Pathol. 2019 Jan;26(1):31-39. doi: 10.1097/PAP.0000000000000215. Review.

PMID:
30256228
49.

Cancerization of the Pancreatic Ducts: Demonstration of a Common and Under-recognized Process Using Immunolabeling of Paired Duct Lesions and Invasive Pancreatic Ductal Adenocarcinoma for p53 and Smad4 Expression.

Hutchings D, Waters KM, Weiss MJ, Wolfgang CL, Makary MA, He J, Cameron JL, Wood LD, Hruban RH.

Am J Surg Pathol. 2018 Nov;42(11):1556-1561. doi: 10.1097/PAS.0000000000001148.

50.

Precancerous neoplastic cells can move through the pancreatic ductal system.

Makohon-Moore AP, Matsukuma K, Zhang M, Reiter JG, Gerold JM, Jiao Y, Sikkema L, Attiyeh MA, Yachida S, Sandone C, Hruban RH, Klimstra DS, Papadopoulos N, Nowak MA, Kinzler KW, Vogelstein B, Iacobuzio-Donahue CA.

Nature. 2018 Sep;561(7722):201-205. doi: 10.1038/s41586-018-0481-8. Epub 2018 Sep 3.

Supplemental Content

Loading ...
Support Center